December 23, 2025
Novo Nordisk A/S: Wegovy® pill approved in the US as first oral GLP-1 for weight management
Wegovy® pill showed a mean weight loss of 16.6% in the OASIS 4 trial1Wegovy® pill is indicated to reduce excess…
Pharmaceuticals, Biotechnology and Life Sciences
Wegovy® pill showed a mean weight loss of 16.6% in the OASIS 4 trial1Wegovy® pill is indicated to reduce excess…
FOSTER CITY, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical…
TARRYTOWN, N.Y., Dec. 22, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation at the 44th Annual…
Windward Bio and Qyuns Therapeutics announce licensing agreement for WIN027, a highly potent, long-acting bispecific antibody with best-in-disease potential in…
MELBOURNE, Australia and INDIANAPOLIS, Dec. 22, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today provides…
ZHUHAI, China, Dec. 18, 2025 (GLOBE NEWSWIRE) — Rezubio, a China-based biotechnology company founded by former Merck scientists, today announced…
Tokyo, Japan and Cambridge, UK, 19 December 2025 – Nxera Pharma Co. Ltd (“Nxera” or “the Company; TSE 4565) today…
San Diego, CA, Dec. 17, 2025 (GLOBE NEWSWIRE) — Sapu BioScience today announced the publication of a new peer-reviewed study…
HONG KONG, Dec. 17, 2025 (GLOBE NEWSWIRE) — Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ: HKPD) (“HKPD” or the…
Arbitration Ruling Reaffirms Allogene’s Full Control of Cemacabtagene Ansegedleucel (Cema-Cel)Decision Reconfirms Allogene’s Expanded Sub-License Covering EU and UK Rights with…